Pediatric Drug DevelopmentProblems and Issues
Decades of Missing Information
Differences in Trial Design - Different “Priors”
Evolving Nature of Pediatric Endpoints
Paucity of Developed Infrastructure
Difficulty in Obtaining Measurements
Communication in a Rapidly Changing Milieu